Global Oral Hypoglycemic Agents Supply, Demand and Key Producers, 2023-2029

Page: 114

Published Date: 13 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Oral Hypoglycemic Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The drugs can treat diabete by reducing glucose concentrations. These drugs mainly focus on the Type 2 diabetes. Oral drugs can control the glucose by stimulating the islet cells.

The drugs can treat diabetic by reducing glucose concentrations.

This report studies the global Oral Hypoglycemic Agents demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oral Hypoglycemic Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Hypoglycemic Agents that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oral Hypoglycemic Agents total market, 2018-2029, (USD Million)
Global Oral Hypoglycemic Agents total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Oral Hypoglycemic Agents total market, key domestic companies and share, (USD Million)
Global Oral Hypoglycemic Agents revenue by player and market share 2018-2023, (USD Million)
Global Oral Hypoglycemic Agents total market by Type, CAGR, 2018-2029, (USD Million)
Global Oral Hypoglycemic Agents total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Oral Hypoglycemic Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly and Company, Janssen Pharmaceuticals, Astellas Pharma Inc., AstraZeneca plc, Sanofi S.A., Takeda, Pfizer Inc, Beohringer Ingelgeim and Merk and Co., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Hypoglycemic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Oral Hypoglycemic Agents Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Oral Hypoglycemic Agents Market, Segmentation by Type
Liquid
Capsule
Tablet

Global Oral Hypoglycemic Agents Market, Segmentation by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Companies Profiled:
Eli Lilly and Company
Janssen Pharmaceuticals
Astellas Pharma Inc.
AstraZeneca plc
Sanofi S.A.
Takeda
Pfizer Inc
Beohringer Ingelgeim
Merk and Co.
Bristol Myers Squibb
Novartis International AG
Abbott Laboratories
Biocon Limited

Key Questions Answered
1. How big is the global Oral Hypoglycemic Agents market?
2. What is the demand of the global Oral Hypoglycemic Agents market?
3. What is the year over year growth of the global Oral Hypoglycemic Agents market?
4. What is the total value of the global Oral Hypoglycemic Agents market?
5. Who are the major players in the global Oral Hypoglycemic Agents market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Oral Hypoglycemic Agents Introduction
    1.2 World Oral Hypoglycemic Agents Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Oral Hypoglycemic Agents Total Market by Region (by Headquarter Location)
        1.3.1 World Oral Hypoglycemic Agents Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Oral Hypoglycemic Agents Market Size (2018-2029)
        1.3.3 China Oral Hypoglycemic Agents Market Size (2018-2029)
        1.3.4 Europe Oral Hypoglycemic Agents Market Size (2018-2029)
        1.3.5 Japan Oral Hypoglycemic Agents Market Size (2018-2029)
        1.3.6 South Korea Oral Hypoglycemic Agents Market Size (2018-2029)
        1.3.7 ASEAN Oral Hypoglycemic Agents Market Size (2018-2029)
        1.3.8 India Oral Hypoglycemic Agents Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oral Hypoglycemic Agents Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oral Hypoglycemic Agents Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.2 World Oral Hypoglycemic Agents Consumption Value by Region
        2.2.1 World Oral Hypoglycemic Agents Consumption Value by Region (2018-2023)
        2.2.2 World Oral Hypoglycemic Agents Consumption Value Forecast by Region (2024-2029)
    2.3 United States Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.4 China Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.5 Europe Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.6 Japan Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.7 South Korea Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.8 ASEAN Oral Hypoglycemic Agents Consumption Value (2018-2029)
    2.9 India Oral Hypoglycemic Agents Consumption Value (2018-2029)

3 World Oral Hypoglycemic Agents Companies Competitive Analysis
    3.1 World Oral Hypoglycemic Agents Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oral Hypoglycemic Agents Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oral Hypoglycemic Agents in 2022
        3.2.3 Global Concentration Ratios (CR8) for Oral Hypoglycemic Agents in 2022
    3.3 Oral Hypoglycemic Agents Company Evaluation Quadrant
    3.4 Oral Hypoglycemic Agents Market: Overall Company Footprint Analysis
        3.4.1 Oral Hypoglycemic Agents Market: Region Footprint
        3.4.2 Oral Hypoglycemic Agents Market: Company Product Type Footprint
        3.4.3 Oral Hypoglycemic Agents Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oral Hypoglycemic Agents Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oral Hypoglycemic Agents Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Oral Hypoglycemic Agents Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Oral Hypoglycemic Agents Consumption Value Comparison
        4.2.1 United States VS China: Oral Hypoglycemic Agents Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Oral Hypoglycemic Agents Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Oral Hypoglycemic Agents Companies and Market Share, 2018-2023
        4.3.1 United States Based Oral Hypoglycemic Agents Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oral Hypoglycemic Agents Revenue, (2018-2023)
    4.4 China Based Companies Oral Hypoglycemic Agents Revenue and Market Share, 2018-2023
        4.4.1 China Based Oral Hypoglycemic Agents Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oral Hypoglycemic Agents Revenue, (2018-2023)
    4.5 Rest of World Based Oral Hypoglycemic Agents Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Oral Hypoglycemic Agents Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oral Hypoglycemic Agents Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Oral Hypoglycemic Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Liquid
        5.2.2 Capsule
        5.2.3 Tablet
    5.3 Market Segment by Type
        5.3.1 World Oral Hypoglycemic Agents Market Size by Type (2018-2023)
        5.3.2 World Oral Hypoglycemic Agents Market Size by Type (2024-2029)
        5.3.3 World Oral Hypoglycemic Agents Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Oral Hypoglycemic Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Oral Hypoglycemic Agents Market Size by Application (2018-2023)
        6.3.2 World Oral Hypoglycemic Agents Market Size by Application (2024-2029)
        6.3.3 World Oral Hypoglycemic Agents Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Eli Lilly and Company
        7.1.1 Eli Lilly and Company Details
        7.1.2 Eli Lilly and Company Major Business
        7.1.3 Eli Lilly and Company Oral Hypoglycemic Agents Product and Services
        7.1.4 Eli Lilly and Company Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Eli Lilly and Company Recent Developments/Updates
        7.1.6 Eli Lilly and Company Competitive Strengths & Weaknesses
    7.2 Janssen Pharmaceuticals
        7.2.1 Janssen Pharmaceuticals Details
        7.2.2 Janssen Pharmaceuticals Major Business
        7.2.3 Janssen Pharmaceuticals Oral Hypoglycemic Agents Product and Services
        7.2.4 Janssen Pharmaceuticals Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Janssen Pharmaceuticals Recent Developments/Updates
        7.2.6 Janssen Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Astellas Pharma Inc.
        7.3.1 Astellas Pharma Inc. Details
        7.3.2 Astellas Pharma Inc. Major Business
        7.3.3 Astellas Pharma Inc. Oral Hypoglycemic Agents Product and Services
        7.3.4 Astellas Pharma Inc. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Astellas Pharma Inc. Recent Developments/Updates
        7.3.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
    7.4 AstraZeneca plc
        7.4.1 AstraZeneca plc Details
        7.4.2 AstraZeneca plc Major Business
        7.4.3 AstraZeneca plc Oral Hypoglycemic Agents Product and Services
        7.4.4 AstraZeneca plc Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 AstraZeneca plc Recent Developments/Updates
        7.4.6 AstraZeneca plc Competitive Strengths & Weaknesses
    7.5 Sanofi S.A.
        7.5.1 Sanofi S.A. Details
        7.5.2 Sanofi S.A. Major Business
        7.5.3 Sanofi S.A. Oral Hypoglycemic Agents Product and Services
        7.5.4 Sanofi S.A. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Sanofi S.A. Recent Developments/Updates
        7.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
    7.6 Takeda
        7.6.1 Takeda Details
        7.6.2 Takeda Major Business
        7.6.3 Takeda Oral Hypoglycemic Agents Product and Services
        7.6.4 Takeda Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Takeda Recent Developments/Updates
        7.6.6 Takeda Competitive Strengths & Weaknesses
    7.7 Pfizer Inc
        7.7.1 Pfizer Inc Details
        7.7.2 Pfizer Inc Major Business
        7.7.3 Pfizer Inc Oral Hypoglycemic Agents Product and Services
        7.7.4 Pfizer Inc Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Pfizer Inc Recent Developments/Updates
        7.7.6 Pfizer Inc Competitive Strengths & Weaknesses
    7.8 Beohringer Ingelgeim
        7.8.1 Beohringer Ingelgeim Details
        7.8.2 Beohringer Ingelgeim Major Business
        7.8.3 Beohringer Ingelgeim Oral Hypoglycemic Agents Product and Services
        7.8.4 Beohringer Ingelgeim Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Beohringer Ingelgeim Recent Developments/Updates
        7.8.6 Beohringer Ingelgeim Competitive Strengths & Weaknesses
    7.9 Merk and Co.
        7.9.1 Merk and Co. Details
        7.9.2 Merk and Co. Major Business
        7.9.3 Merk and Co. Oral Hypoglycemic Agents Product and Services
        7.9.4 Merk and Co. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Merk and Co. Recent Developments/Updates
        7.9.6 Merk and Co. Competitive Strengths & Weaknesses
    7.10 Bristol Myers Squibb
        7.10.1 Bristol Myers Squibb Details
        7.10.2 Bristol Myers Squibb Major Business
        7.10.3 Bristol Myers Squibb Oral Hypoglycemic Agents Product and Services
        7.10.4 Bristol Myers Squibb Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Bristol Myers Squibb Recent Developments/Updates
        7.10.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.11 Novartis International AG
        7.11.1 Novartis International AG Details
        7.11.2 Novartis International AG Major Business
        7.11.3 Novartis International AG Oral Hypoglycemic Agents Product and Services
        7.11.4 Novartis International AG Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Novartis International AG Recent Developments/Updates
        7.11.6 Novartis International AG Competitive Strengths & Weaknesses
    7.12 Abbott Laboratories
        7.12.1 Abbott Laboratories Details
        7.12.2 Abbott Laboratories Major Business
        7.12.3 Abbott Laboratories Oral Hypoglycemic Agents Product and Services
        7.12.4 Abbott Laboratories Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Abbott Laboratories Recent Developments/Updates
        7.12.6 Abbott Laboratories Competitive Strengths & Weaknesses
    7.13 Biocon Limited
        7.13.1 Biocon Limited Details
        7.13.2 Biocon Limited Major Business
        7.13.3 Biocon Limited Oral Hypoglycemic Agents Product and Services
        7.13.4 Biocon Limited Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Biocon Limited Recent Developments/Updates
        7.13.6 Biocon Limited Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oral Hypoglycemic Agents Industry Chain
    8.2 Oral Hypoglycemic Agents Upstream Analysis
    8.3 Oral Hypoglycemic Agents Midstream Analysis
    8.4 Oral Hypoglycemic Agents Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oral Hypoglycemic Agents Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Oral Hypoglycemic Agents Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Oral Hypoglycemic Agents Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Oral Hypoglycemic Agents Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Oral Hypoglycemic Agents Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oral Hypoglycemic Agents Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Oral Hypoglycemic Agents Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Oral Hypoglycemic Agents Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Oral Hypoglycemic Agents Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Oral Hypoglycemic Agents Players in 2022
    Table 12. World Oral Hypoglycemic Agents Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Oral Hypoglycemic Agents Company Evaluation Quadrant
    Table 14. Head Office of Key Oral Hypoglycemic Agents Player
    Table 15. Oral Hypoglycemic Agents Market: Company Product Type Footprint
    Table 16. Oral Hypoglycemic Agents Market: Company Product Application Footprint
    Table 17. Oral Hypoglycemic Agents Mergers & Acquisitions Activity
    Table 18. United States VS China Oral Hypoglycemic Agents Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Oral Hypoglycemic Agents Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Oral Hypoglycemic Agents Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oral Hypoglycemic Agents Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Oral Hypoglycemic Agents Revenue Market Share (2018-2023)
    Table 23. China Based Oral Hypoglycemic Agents Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oral Hypoglycemic Agents Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Oral Hypoglycemic Agents Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Oral Hypoglycemic Agents Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oral Hypoglycemic Agents Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Oral Hypoglycemic Agents Revenue Market Share (2018-2023)
    Table 29. World Oral Hypoglycemic Agents Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Oral Hypoglycemic Agents Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Oral Hypoglycemic Agents Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Oral Hypoglycemic Agents Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Oral Hypoglycemic Agents Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Oral Hypoglycemic Agents Market Size by Application (2024-2029) & (USD Million)
    Table 35. Eli Lilly and Company Basic Information, Area Served and Competitors
    Table 36. Eli Lilly and Company Major Business
    Table 37. Eli Lilly and Company Oral Hypoglycemic Agents Product and Services
    Table 38. Eli Lilly and Company Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Eli Lilly and Company Recent Developments/Updates
    Table 40. Eli Lilly and Company Competitive Strengths & Weaknesses
    Table 41. Janssen Pharmaceuticals Basic Information, Area Served and Competitors
    Table 42. Janssen Pharmaceuticals Major Business
    Table 43. Janssen Pharmaceuticals Oral Hypoglycemic Agents Product and Services
    Table 44. Janssen Pharmaceuticals Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Janssen Pharmaceuticals Recent Developments/Updates
    Table 46. Janssen Pharmaceuticals Competitive Strengths & Weaknesses
    Table 47. Astellas Pharma Inc. Basic Information, Area Served and Competitors
    Table 48. Astellas Pharma Inc. Major Business
    Table 49. Astellas Pharma Inc. Oral Hypoglycemic Agents Product and Services
    Table 50. Astellas Pharma Inc. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Astellas Pharma Inc. Recent Developments/Updates
    Table 52. Astellas Pharma Inc. Competitive Strengths & Weaknesses
    Table 53. AstraZeneca plc Basic Information, Area Served and Competitors
    Table 54. AstraZeneca plc Major Business
    Table 55. AstraZeneca plc Oral Hypoglycemic Agents Product and Services
    Table 56. AstraZeneca plc Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. AstraZeneca plc Recent Developments/Updates
    Table 58. AstraZeneca plc Competitive Strengths & Weaknesses
    Table 59. Sanofi S.A. Basic Information, Area Served and Competitors
    Table 60. Sanofi S.A. Major Business
    Table 61. Sanofi S.A. Oral Hypoglycemic Agents Product and Services
    Table 62. Sanofi S.A. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Sanofi S.A. Recent Developments/Updates
    Table 64. Sanofi S.A. Competitive Strengths & Weaknesses
    Table 65. Takeda Basic Information, Area Served and Competitors
    Table 66. Takeda Major Business
    Table 67. Takeda Oral Hypoglycemic Agents Product and Services
    Table 68. Takeda Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Takeda Recent Developments/Updates
    Table 70. Takeda Competitive Strengths & Weaknesses
    Table 71. Pfizer Inc Basic Information, Area Served and Competitors
    Table 72. Pfizer Inc Major Business
    Table 73. Pfizer Inc Oral Hypoglycemic Agents Product and Services
    Table 74. Pfizer Inc Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Pfizer Inc Recent Developments/Updates
    Table 76. Pfizer Inc Competitive Strengths & Weaknesses
    Table 77. Beohringer Ingelgeim Basic Information, Area Served and Competitors
    Table 78. Beohringer Ingelgeim Major Business
    Table 79. Beohringer Ingelgeim Oral Hypoglycemic Agents Product and Services
    Table 80. Beohringer Ingelgeim Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Beohringer Ingelgeim Recent Developments/Updates
    Table 82. Beohringer Ingelgeim Competitive Strengths & Weaknesses
    Table 83. Merk and Co. Basic Information, Area Served and Competitors
    Table 84. Merk and Co. Major Business
    Table 85. Merk and Co. Oral Hypoglycemic Agents Product and Services
    Table 86. Merk and Co. Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Merk and Co. Recent Developments/Updates
    Table 88. Merk and Co. Competitive Strengths & Weaknesses
    Table 89. Bristol Myers Squibb Basic Information, Area Served and Competitors
    Table 90. Bristol Myers Squibb Major Business
    Table 91. Bristol Myers Squibb Oral Hypoglycemic Agents Product and Services
    Table 92. Bristol Myers Squibb Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Bristol Myers Squibb Recent Developments/Updates
    Table 94. Bristol Myers Squibb Competitive Strengths & Weaknesses
    Table 95. Novartis International AG Basic Information, Area Served and Competitors
    Table 96. Novartis International AG Major Business
    Table 97. Novartis International AG Oral Hypoglycemic Agents Product and Services
    Table 98. Novartis International AG Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Novartis International AG Recent Developments/Updates
    Table 100. Novartis International AG Competitive Strengths & Weaknesses
    Table 101. Abbott Laboratories Basic Information, Area Served and Competitors
    Table 102. Abbott Laboratories Major Business
    Table 103. Abbott Laboratories Oral Hypoglycemic Agents Product and Services
    Table 104. Abbott Laboratories Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Abbott Laboratories Recent Developments/Updates
    Table 106. Biocon Limited Basic Information, Area Served and Competitors
    Table 107. Biocon Limited Major Business
    Table 108. Biocon Limited Oral Hypoglycemic Agents Product and Services
    Table 109. Biocon Limited Oral Hypoglycemic Agents Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of Oral Hypoglycemic Agents Upstream (Raw Materials)
    Table 111. Oral Hypoglycemic Agents Typical Customers
List of Figure
    Figure 1. Oral Hypoglycemic Agents Picture
    Figure 2. World Oral Hypoglycemic Agents Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Oral Hypoglycemic Agents Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Oral Hypoglycemic Agents Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oral Hypoglycemic Agents Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Oral Hypoglycemic Agents Revenue (2018-2029) & (USD Million)
    Figure 13. Oral Hypoglycemic Agents Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Oral Hypoglycemic Agents Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Oral Hypoglycemic Agents Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Oral Hypoglycemic Agents by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oral Hypoglycemic Agents Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oral Hypoglycemic Agents Markets in 2022
    Figure 27. United States VS China: Oral Hypoglycemic Agents Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Oral Hypoglycemic Agents Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Oral Hypoglycemic Agents Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Oral Hypoglycemic Agents Market Size Market Share by Type in 2022
    Figure 31. Liquid
    Figure 32. Capsule
    Figure 33. Tablet
    Figure 34. World Oral Hypoglycemic Agents Market Size Market Share by Type (2018-2029)
    Figure 35. World Oral Hypoglycemic Agents Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Oral Hypoglycemic Agents Market Size Market Share by Application in 2022
    Figure 37. Hospital Pharmacies
    Figure 38. Retail Pharmacies
    Figure 39. Online Pharmacies
    Figure 40. Oral Hypoglycemic Agents Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Oral Hypoglycemic Agents Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Oral Hypoglycemic Agents Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Oral Hypoglycemic Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Oral Hypoglycemic Agents Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Oral Hypoglycemic Agents Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 09 Jan 2022

date Pharma & Healthcare

Global Oral Hypoglycemic Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Oral Hypoglycemic Agents Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 04 Jan 2023

date Pharma & Healthcare

The drugs can treat diabetic by reducing glucose concentrations.

Global Oral Hypoglycemic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Oral Hypoglycemic Agents Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 15 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Oral Hypoglycemic Agents market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

oral hypoglycemic agents

oral hypoglycemic agents ohas

oral hypoglycemic agents insulin analogues

oral hypoglycemic agents insulin injection

oral hypoglycemic agents insulin injection production demand producers

Oral Hypoglycemic Agents (OHAs)

Oral Hypoglycemic Agents and Insulin Analogues

Oral Hypoglycemic Agents and Insulin Injection

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>